David N. Vaughan is a neurologist based in Heidelberg, VIC. His practice address is 245 Burgundy Street, Heidelberg, VIC 3084, Australia. Neurology can feel like a big word, but the work is often about practical support—understanding symptoms, finding likely causes, and helping people manage day to day life more safely.
David looks after people with a range of nervous system conditions. This includes different types of seizures, such as absence seizures, focal (partial) seizures, and generalised tonic-clonic seizures. He also supports patients with epilepsy that links to triggers like photosensitive epilepsy, where light patterns can play a role. At times, this care can include myoclonic epilepsy and conditions such as Lennox-Gastaut syndrome (LGS), which can be complex and needs careful planning.
Memory issues are also part of the work. For some people, that means helping with ongoing concerns like memory loss and conditions that affect thinking and memory, including Alzheimer’s disease. There are also rarer neurological problems that may come up in consultation, such as Lafora disease and periventricular heterotopia.
David also deals with movement and balance related problems. For example, drug-induced dyskinesia can happen after certain medicines, and it can be stressful when symptoms change. Another condition sometimes discussed is primary lateral sclerosis, along with other related disorders where nerves in the brain and spinal cord are affected.
Over time, he focuses on working out what is going on and what options make sense for each person. Treatment might involve medication changes, monitoring side effects, and planning around seizure risk. In many cases, it also means talking through what to expect, what to watch for, and when to seek help urgently.
Epilepsy care often comes with a lot of questions, from triggers and safety at home to school or work routines. David helps patients and families sort through those questions calmly, using up-to-date evidence and clear explanations, rather than heavy jargon. If clinical trials are ever relevant, they can be discussed as part of the overall conversation, depending on the situation.
